May 2024 FDA Recall Drug by Remedyrepack Inc.
D-0549-2024 - Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.

This Class II drug recall was voluntarily initiated by Remedyrepack Inc. on May 31, 2024 for the product Drug. The FDA reported the reason for recall as product mix up. a bottle labeled as phenazopyridine hcl tablets usp 100 mg contained phenobarbital tablets 16.2 mg.. The product was distributed in Product was distributed to one medical facility. and the recall is currently terminated.

Recall Number: D-0549-2024

Reason for Recall
Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.
Initiated
05-31-2024
Reported
06-19-2024
Quantity
8 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Product was distributed to one medical facility.
Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., Indiana, PA NDC#: 70518-0218-00, Source NDC: 75826-0114-10 MFG: Winder Laboratories, LLC, Winder, GA

Batch or Lot Expiration Information

Lot# B2906961-042524, exp. date 02/26/2027